XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2022
Finite Lived Intangible Assets [Line Items]      
Net Carrying Amount $ 11,537,000   $ 11,962,000
Amortization expense 400,000 $ 400,000  
Novartis      
Finite Lived Intangible Assets [Line Items]      
Gross Carrying Amount 24,857,000   24,857,000
Accumulated Amortization 13,320,000   12,895,000
Impairment 0   0
Net Carrying Amount 11,537,000   11,962,000
Novartis | Patents      
Finite Lived Intangible Assets [Line Items]      
Gross Carrying Amount 21,728,000   21,728,000
Accumulated Amortization 12,158,000   11,770,000
Impairment 0   0
Net Carrying Amount $ 9,570,000   $ 9,958,000
Useful Lives 14 years   14 years
Novartis | License      
Finite Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 3,129,000   $ 3,129,000
Accumulated Amortization 1,162,000   1,125,000
Impairment 0   0
Net Carrying Amount $ 1,967,000   $ 2,004,000
Useful Lives 21 years   21 years